Azul 3D

Azul 3D develops high area rapid printing 3D printers based on stereolithography technology, enabling mass manufacturing on a single streamlined production platform using multiple materials including rubber, ceramic, resins, and flexible materials. The company has evolved its proprietary HARP technology into a fully digital optical manufacturing platform specifically designed for prescription lens fabrication and beyond. The system replaces traditional overseas lens casting processes with lab-ready technology that uses 80% less material, enables full freeform manufacturing, and supports design of lenses impossible to produce with conventional methods. Azul 3D's platform is compatible with LMS systems, lab processing, hard coats, tints, mirror finishes, and anti-reflective coatings, producing optical-grade parts with 56 ABBE value, over 90% luminous transmittance, and less than 1% haze. The continuous printing process creates a single polymer network without layers, with in-process thermal control maintaining consistency across large production volumes, supporting lens diameters up to 90mm with compatible Rx ranges from -10 to +6. Founded in 2016 and headquartered in Skokie, Illinois, the company has raised approximately $39.5M in Series A funding from investors including Rocky Point Ventures, DuPont, GS Futures, Beta Lab, and Exposition Ventures. Azul 3D differentiates itself through its HARP-enabled continuous stereolithography platform that delivers fully digital optical manufacturing for prescription lenses with material efficiency and freeform geometry capabilities impossible with traditional casting.